CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Kymera Therapeutics, Inc. - KYMR CFD

34.88
1.15%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.12
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 35.52
Open 35.22
1-Year Change 21.36%
Day's Range 34.56 - 35.56
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
May 17, 2024 34.88 -0.34 -0.97% 35.22 35.62 34.50
May 16, 2024 35.52 0.42 1.20% 35.10 35.80 34.68
May 15, 2024 35.87 0.25 0.70% 35.62 36.77 35.14
May 14, 2024 35.04 -3.31 -8.63% 38.35 39.13 34.03
May 13, 2024 38.30 0.44 1.16% 37.86 38.87 37.86
May 10, 2024 37.81 -0.78 -2.02% 38.59 38.83 37.58
May 9, 2024 38.54 0.46 1.21% 38.08 39.38 37.77
May 8, 2024 38.46 0.75 1.99% 37.71 38.84 37.32
May 7, 2024 38.40 0.14 0.37% 38.26 38.98 37.98
May 6, 2024 38.24 0.86 2.30% 37.38 38.45 36.99
May 3, 2024 37.27 1.01 2.79% 36.26 38.07 35.96
May 2, 2024 36.18 0.64 1.80% 35.54 36.47 34.97
May 1, 2024 36.13 2.64 7.88% 33.49 37.48 33.49
Apr 30, 2024 33.54 -0.43 -1.27% 33.97 34.43 33.46
Apr 29, 2024 34.62 1.16 3.47% 33.46 34.62 33.42
Apr 26, 2024 33.31 0.35 1.06% 32.96 34.04 32.96
Apr 25, 2024 33.31 -0.53 -1.57% 33.84 34.21 32.54
Apr 24, 2024 35.15 0.19 0.54% 34.96 35.85 34.55
Apr 23, 2024 35.64 1.32 3.85% 34.32 36.88 34.32
Apr 22, 2024 34.31 -0.16 -0.46% 34.47 35.27 33.77

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Kymera Therapeutics, Inc. Company profile

About Kymera Therapeutics Inc

Kymera Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Its targeted protein degradation (TPD) platform Pegasus, allows it to discover selective small molecule protein degraders with activity against disease-causing proteins throughout the body. The Company’s Pegasus platform includes E3 Ligase Whole-Body Atlas, E3 Ligase Binders Toolbox, Ternary Complex Modeling, Quantitative System Pharmacology Model and Chemistry. Its clinical stage programs include IRAK4, IRAKIMiD, and STAT3, which each address targets within the interleukin-1 receptor/toll-like receptor (IL-1R/TLR), and janus kinase/signal transducers and activators of transcription (JAK/STAT). Its programs focus on treating range of immune-inflammatory diseases, hematologic malignancies, and solid tumors.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Kymera Therapeutics Inc revenues increased from $34M to $72.8M. Net loss applicable to common stockholders increased 83% to $100.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development - increase from $59.8M to $125.3M (expense).

Industry: Biotechnology & Medical Research (NEC)

200 Arsenal Yards Blvd., Suite 230
WATERTOWN
MASSACHUSETTS 02472
US

News

CPI, consumer price index symbol.

Disinflation resumes in the US as CPI drops in April

The rate of growth in US consumer prices dropped in April leading markets to price in more chances of rate cuts from the Fed

11:24, 16 May 2024

Stock market crash: how far can the S&P 500 go?

After a remarkably strong first quarter, the US stock market pulled back in April for the first time since October last year.

11:46, 10 May 2024

Bank of England preview: possible rate cut in summer?

The Bank of England (BoE) is widely expected to keep interest rates unchanged when it meets later this week. Data from Reuters shows a 90% chance of no change to the current rate of 5.25%, but the central bank will need to decide whether to change the messaging about rate cuts this year as traders will be paying close attention to any rate-cut clues.

12:39, 8 May 2024

We’re partnering with Newsquawk

Filter out the noise and focus on the news that matters.

08:32, 23 April 2024

US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft

The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.

15:56, 22 April 2024

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

People also watch

ETH/USD

3,080.07 Price
-1.580% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Gold

2,415.65 Price
+1.590% 1D Chg, %
Long position overnight fee -0.0187%
Short position overnight fee 0.0105%
Overnight fee time 21:00 (UTC)
Spread 1.50

XRP/USD

0.51 Price
-2.550% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

66,294.45 Price
-1.280% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading